Richard McKilligan
Mr. McKilligan will remain as Chief Financial Officer of Graphium Biosciences, Inc., a wholly-owned subsidiary of the Company (“Graphium”).
Highest-materiality recent filing
Tacora Capital commits to purchase $10M of common stock via monthly financings over 12 months; first closing of $1.75M for 6,256,704 shares on May 31.
Range Impact reports Q1 2026: royalty income $915K, debt cut to $1.8M, equity $36.1M
Royalty income surged from $0 in Q1 2025 to $915,380 in Q1 2026.
Range Impact reports FY2025: revenue $3.7M, net income $19.2M vs loss $9.8M prior year
Revenue from continuing operations rose to $3.7M in 2025 vs $0 in 2024; net income of $19.2M vs loss of $9.8M.
Range Impact acquires KY mine complexes, sells AML services business
Acquired Premier Elkhorn (13K surface, 42.5K mineral acres) and Cambrian Coal (2.6K surface) in KY, assuming ~$54M in reclamation bonds.
Range Impact Q3 2025 revenue $778,767; cuts debt by $2.08M, raises $550K from insider
Revenue of $778,767: royalty revenue $569,947 and legacy AML services $208,820.
Range Impact Q2 gross profit $508K; sells non-core permits for $2M value; repays $722K YTD debt
Sold three non-core mining permits at Fola Mine Complex, reducing reclamation obligations by $1,244,560 and earning $800,000 advisory fee.
Acquired two mining permits and one coal lease from WV Reclaim Co, LLC, assuming $10.4M in reclamation obligations.
Range Impact acquires Fola Mine Complex (120K acres), records $51.6M land value
Acquired ~120,000 acres of real property interests at the Fola Mine Complex in West Virginia.
Acquired approx 120,000 acres of real property interests at Fola Mine Complex in WV for $2,958,516 via credit and assumed liabilities.
Range Impact restates Q1 2024 financials; net loss rises $462K due to invoice error
Audit Committee on Aug 7, 2024, concluded March 31, 2024 10-Q should no longer be relied upon.
Range Impact sells non-core assets to cancel $2.94M debt; exits AML business
On Aug 22, 2024, Collins Building sold mechanic shop, stone quarry, vehicles to Collins-owned entities in exchange for discharge of $2,940,836 in promissory notes.
Range Impact reports 2Q 2024 revenue $2.35M (-41% YoY), net loss of $1.23M vs profit in prior year
Consolidated revenue $2.35M down from $3.998M in 2Q 2023; gross profit margin -6.3% vs +21.1%.
Range Impact Q1 2024 revenue rises to $3.9M, net loss widens to $751K
Consolidated revenue $3,909,893 in Q1 2024, up 30% YoY from $3,014,887.
Range Impact promotes Patricia Missal to CFO, plans divestiture of Graphium subsidiary
Patricia Missal promoted from Controller to CFO, replacing Richard McKilligan, effective April 25, 2024.
Range Impact FY 2023 revenue $19.3M, net income $3.1M; guides Q1 2024 rev ~$3.5M
FY 2023 revenue $19.3M, up from $4.8M in FY 2022.
Mr. McKilligan will remain as Chief Financial Officer of Graphium Biosciences, Inc., a wholly-owned subsidiary of the Company (“Graphium”).
On April 25, 2024, the Board of Directors of Range Impact, Inc. (the “Company”) elected Patricia Missal as Chief Financial Officer, replacing Richard McKilligan who had previously served as the Company’s Chief Financial Officer, Counsel and Secretary.
Dr. Brandon Zipp, who had served as the Company’s Chief Science Officer, will, effective April 25, 2024, serve exclusively as the Chief Science Officer of Graphium.
Max materiality 0.85 · Median 0.65 · Most common event other_material